CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 241 enrolled
Drug / intervention
Jetstream Atherectomy Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01436435
NCT01436435Phase 4Completed
CompareCT.gov

Jetstream NAVITUS™ System Endovascular Therapy Post-market Registry (JET)

Boston Scientific Corporation·interventional·Posted Sep 19, 2011·Updated Oct 19, 2016

In Brief

A Phase 4 clinical trial evaluating Jetstream Atherectomy System for Peripheral Arterial Diseases. Completed, enrolled 241 participants across 11 sites.

Detailed Summary

The scope of the JET registry to observe long term treatment effects of Jetstream Navitus on various lesions types/morphologies.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Arterial Diseases
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedSep 19, 2011
Enrollment StartSep 1, 2011
Primary CompletionFeb 1, 2016
TodayJul 2, 2026
Enrollment to primary: 4.4 yearsPosted 14.8 years ago

Interventions

Jetstream Atherectomy Systemdevice

Atherectomy